Drug shortage
Extended Release · Mylan Pharmaceuticals Inc., a Viatris Company
FDA drug shortage · To Be Discontinued · updated Jan 8, 2026
Key facts
| Generic name | Extended Release, Methylphenidate Transdermal Film |
|---|---|
| Company | Mylan Pharmaceuticals Inc., a Viatris Company |
| Presentation | Methylphenidate, Transdermal Film, Extended Release, 20mg/9hrs (NDC 0378-8262-93) |
| Status | To Be Discontinued |
| Therapeutic category | Psychiatry |
| Package NDCs | 0378-8262-93 |
| First posted | Feb 28, 2025 |
| Last updated | Jan 8, 2026 |
| Discontinued | Jan 8, 2026 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: